Researchers applied machine learning to predict depressive symptoms, revealing sleep quality and anxiety as key factors across diverse populations and datasets.
Zevra sells priority review voucher for $150m to support drug launches – Pharmaceutical Technology
The rare paediatric disease PRV program aims to incentivise drug development for rare paediatric diseases. Credit: MagicVectorCreation via Getty Images. Zevra has sold its US